GENEVA, July 18 -- Q32 BIO INC. filed a patent application (US2026/010721) for “TREATMENT OF T-CELL MEDIATED INFLAMMATORY AND/OR AUTOIMMUNE DISEASE”. With publication no. WO/2026/151947, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....